# The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients

> **NCT04817397** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 100 (actual)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04817397
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-20
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817397, "The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04817397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*